Andrew Mendiola, received a K99 award from the National Institute of Neurological Disorders and Stroke for his project “Epigenomic regulation of oxidative stress-producing innate immunity in neuroinflammation.” The purpose of the NIH Pathway to Independence Award (K99/R00) program is to facilitate a timely transition of outstanding postdoctoral researchers with a research and/or clinical doctorate degree […]
Katerina Akassoglou, PhD, has been elected into the American Association for the Advancement of Science (AAAS), a lifetime distinction by the world’s largest general scientific society. “I’m grateful to my lab members and collaborators for their immeasurable contributions to these studies over the past 20 years. Election to AAAS further encourages us to follow our curiosity […]
Katerina Akassoglou, PhD, senior investigator at Gladstone Institutes, has been named a fellow of the National Academy of Inventors (NAI). Election to NAI is the highest professional distinction given solely to academic inventors. “Election to the NAI further encourages us to pursue challenging problems in biology and medicine to develop urgently needed treatments for devastating human diseases.”
Dr. Katerina Akassoglou, named one of the Most Influential Women in Bay Area Business. To view the full article, click here.
Study by the Akassoglou Lab showed that blocking a particular receptor protein of the BMP signaling pathway, effectively promoted the maturation of myelin-producing cells and myelin repair. To read the full article, click here.
Members of Akassoglou Lab working on a new study for new line of drugs to potentially stimulate myelin repair in the presence of toxic blood leaks in the brain. To view the full article, click here.
The Akassoglou Lab showed toxic blood leaks in the brain inhibiting remyelination with implications for the development of therapeutic strategies for neuro-repair in multiple sclerosis and other neurological diseases with blood-brain barrier disruption and myelin damage. From Petersen et al. BMP receptor blockade overcomes extrinsic inhibition of remyelination and restores neurovascular homeostasis. Pp. 2291-2301.
Scientists at Akassoglou Lab identifying toxic elements that inhibit repair of damaged myelin and producing studies to find new treatments. To view full article click here.
Since 1985, the Alzheimer’s Disease Research (ADR) program has awarded nearly $140 million to support promising research in fields ranging from molecular biology to genetics to epidemiology. ADR is currently supporting 133 outstanding biomedical researcher projects.
A small team of scientists at the Akassoglou Lab is working on what could be a big breakthrough in treating dementia and other brain diseases. To read full article , click here.
